baber/WOPTO huggingface dataset:
Patent NZ-337923-A (NZ)
Title: Administration of an injectable antibiotic, ceftiofur crystalline free acid, subcutaneously in the posterior ear of an animal
Inventor: BROWN SCOTT A
IPC: A61K31/545
Filed: 1998-03-16
Abstract: A method of administrating an antibiotic by subcutaneous injection in the ear of an animal such as cattle, swine, sheep and goats.  Injectable antibiotics include the following: injectable suspensions of sparingly water-soluble antimicrobial agents, such as procaine penicillin, benzathine penicillin, ceftiofur crystalline free acid ceftiofur hydrochloride, ampicillin trihydrate and amoxicillin trihydrate; sustained-release non-aqueous solutions of sparingly water-soluble antimicrobial agents, such as oxytetracycline, erythromycin, tylosin, tilmicosin and florfenicol; and injectable solutions of zwitterionic antimicrobial agents, such as enrofloxacin, danofloxacin and premafloxacin. Specifically, a method of injecting a relatively large volume (1 to 15 mL) of a sterile oil suspension of an antibiotic, such as ceftiofur crystalline free acid ie. 7-[2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino)acetamido]-3-[(fur-2-ylcarbonyl)thiomethyl]-3-cephem-4-carboxylic acid (see formula I), in the posterior of the ear of cattle and swine.
Patent NZ-502261-A (NZ)
Title: Controlled release oral pharmaceutical containing an opioid analgesic in crystal form with particle size of between 10 microns to 3 mm
Inventor: BETZING JURGEN
IPC: A61K9/50
Filed: 2000-01-11
Abstract: An oral controlled release preparation with at least one controlled release coating contains an opioid analgesic in the form of crystals having a particle size of 10mm to 3mm provided that the analgesic is not morphine or a salt thereof.
Patent NZ-505678-A (NZ)
Title: Anchor sheet, for floor covering, with hooks on top for hook and loop attachment, and overlap and underlap portions
Inventor: PACIONE JOSEPH R
IPC: D06N7/00
Filed: 1999-01-11
Abstract: The anchor sheet has hooks on its top surface, and has overlap and underlap portions, so that the sheets can be placed side by side.
Patent NZ-509362-A (NZ)
Title: Optical element with a microprism structure for deflecting light beams
Inventor: SEJKORA GUNTHER
IPC: G02B5/04
Filed: 2000-04-20
Abstract: An optical element (10, 10', 10'') for deflecting light beams (18, 19), which enter and re-emerge from the latter, in such a way that their angle of emergence (gamma) is limited, in particular for use as a luminaire-cover, having a plate-like core (11, 11', 11'') of transparent material which on one side is occupied by microprisms (12, 13) that taper-starting from their root (15)-forming furrows (22), wherein all of the top surfaces (14) of the microprisms form the light-entry face and the other side (21) of the core forms the light-emergence face, and wherein the top surfaces (14) of the microprisms are formed convexly or concavely in a continuous or non-continuous manner, and also a method for producing the optical element (10, 10', 10'').
Patent NZ-515425-A (NZ)
Title: Method and punch form for die-cutting of packaging material and the use thereof
Inventor: CAVLIN SOREN
IPC: B31B1/14
Filed: 2000-02-15
Abstract: A punch form (1) for die-cutting of packaging material (7), comprising cutting knives and/or scoring rules, wherein the punch form at least partly is provided with sheet material provided in such a way that a crack-reducing effect is achieved in the packaging material, at least in connection to the cutting knives and/or scoring rules, wherein the sheet material is air permeable to during die-cutting evacuate air between the packaging material and the parts of the punch form which are provided with sheet material; a method for die-cutting packaging material by means of a punch form as above, in which air between the packaging material and the punch form provided with sheet material is evacuated; and the use of a punch form as above.
Patent NZ-516616-A (NZ)
Title: Beta-carboline pharmaceutical compositions
Inventor: OREN PETER L
IPC: A61K9/66
Filed: 2000-04-26
Abstract: A pharmaceutical formulation comprising an active compound of formula (I) wherein said compound is provided as: free drug; a water-soluble diluent; a lubricant; a hydrophilic binder selected from the group consisting of a cellulose derivative, povidone, and a mixture thereof; a disintegrant selected from the group consisting of croscarmellose sodium, crospovidone, and a mixture thereof. for use in treating sexual dysfunction.
Patent NZ-516702-A (NZ)
Title: Catalytic anti-factor VIII allo-antibodies
Inventor: KAVERI SRINIVAS
IPC: A61K38/08
Filed: 2000-07-18
Abstract: Disclosed are anti-Factor VIII allo-antibodies capable of catalyzing the degradation of Factor VIII. Also disclosed are anti-Factor VIII allo-antibody-catalysed Factor VIII degradation inhibitors, and a method of determining their presence thereof in a mammal. Further disclosed is the use of the above antibodies and inhibitors in medical treatment.
Patent NZ-517294-A (NZ)
Title: Purine derivatives
Inventor: MONAGHAN SANDRA MARINA
IPC: A61P25/08
Filed: 2000-10-06
Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds as adenosine A2a receptor agonists.
Patent NZ-521550-A (NZ)
Title: Antitumoral ecteinascidin derivatives
Inventor: FLORES MARIA
IPC: A61K31/4985
Filed: 2001-04-12
Abstract: An ecteinascidin derivative has the formula (I) wherein: R1 and R2 are independently H, C(=O)R' or optionally substituted alkyl, alkenyl, alkynyl or aryl; each R' group is independently H, OH, NO2, NH2, SH, CN, halogen, =O, C(=O)H, C(=O)CH3, CO2H or optionally substituted alkyl, alkenyl, alkynyl or aryl; X2 is OX1 or N(X1)2; each X1 is H, C(=O)R' or optionally substituted alkyl, alkenyl, alkynyl or aryl, or two X1 groups may together form a cyclic substituent on the nitrogen atom or X1 can be OSO2CH3 when X2 is OX1; X3 is OR1, CN, =O, or H; X4 is -H or alkyl and X5 is H, or R1 limited by the provisos defined in the specification. The compounds are useful in the treatment of tumours.
Patent NZ-522448-A (NZ)
Title: Crown cap opener
Inventor: TEPPE BRUNO
IPC: B67B7/16
Filed: 2001-04-13
Abstract: The invention concerns a crown cap opener (2) consisting of a handle (4) associated with a bottle opening head (3) comprising a central cut with a support element (17) of a catching member (19) on its edge, the support element being located between the handle (4) and the catching member (19), a device designed to be fixed (1) on the first forefinger and middle finger bone being attached on the handle (4), said fixing device (1) enabling to hold the bottle opener in hand constantly without inconvenience and to open bottles single-handed.
Patent NZ-525581-A (NZ)
Title: Thermal textile that generates heat from electricity
Inventor: DEANGELIS ALFRED R
IPC: D06M15/263
Filed: 2001-10-25
Abstract: A  textile (310) made at least in part with conductive yarns  (12)  for  the  purpose of generating  heat  from  an electrical  power source. The textile (310)  has  conducting yarns  (12)  or  "heaters",  with conductivity  and  spacing tailored  to the electrical source to be used and  the  heat to  be  generated.  The  core yarn (11)  may  be  formed  of monofilaments, multifilaments or staple fibers and is  of  a non-conductive  nature.  The heater yarns  have  a  positive temperature coefficient (PTC) whereby the resistance of  the yarn  increases with an increase in temperature and decrease with  a decrease in temperature. "Leads", such as conductive yarns  (12) can be used to supply electricity to the  heater yarns.  A  coating to the textile can electrically  insulate the  textile  as well as provide protection to  the  textile during  activities such as laundering and use. The insulator (13)  is  made  of  a  non-conductive  material  such  as  a thermoplastic,  thermoset plastic or  a  thermoplastic  that will change to thermoset upon treatment, for example polypropylene.
Patent NZ-525957-A (NZ)
Title: Method of enhancing virus-resistance in plants and producing virus-immune plants
Inventor: CHU PAUL WING GAY
IPC: C12Q1/6895
Filed: 2001-11-16
Abstract: A method for conferring immunity to a pathogenic plant virus on a leguminous plant comprises introducing to the plant a nucleic acid comprising nucleotides encoding a virus encoded coat protein. The nucleic acid is expressed under the control of a strong constitutive promoter selected from (i) a SCSV promoter (ii) a pea rbcS-E9 promoter (iii) a duplicated CaMV35S promoter, (iv) a CaMV 19S promoter; and (v) a A. thaliana SSU promoter.
Patent NZ-527648-A (NZ)
Title: Method for delivery of a bifurcated stent to a target bifurcated body passageway
Inventor: RICCI DONALD R
IPC: A61F2/954
Filed: 1999-07-29
Abstract: Disclosed is a method for delivery to a non-human animal of a bifurcated stent to a target bifurcated body passageway having a proximal body passageway, a first distal body passageway and a second distal body passageway using an endovascular sleeve comprising a first tubular passageway and a second tubular passageway fixed with respect to one another, the first tubular passageway comprising a first distal end and a first proximal end, the second tubular passageway comprising a second distal end and a second proximal end, the first distal end being longer than the second distal end to define a junction which abuts against a crotch in the bifurcated body passageway. (62) Divided out of 510186
Patent NZ-529666-A (NZ)
Title: N-phenylpyrrole guanidine derivatives as melanocortin reception ligands
Inventor: LUNDSTEDT TORBJORN
IPC: A61P29/00
Filed: 2002-08-06
Abstract: Phenyl pyrrole aminoguanidine compounds of the formula (I) and the pharmacologically active salts thereof as ligands to the melanocortin receptors are disclosed, wherein the variables are as defined in the specification. These compounds are suitable for the treatment of disorders in the melanocortin system.
Patent NZ-531293-A (NZ)
Title: Pharamceuticals containing 1,4-benzothiepine-1,1-dioxide derivatives and another active substances such as ezetimibe, pamaqueside or tiqueside for treating lipid metabolism and atherosclerotic disorders
Inventor: GLOMBIK HEINER
IPC: A61K45/06
Filed: 2002-08-09
Abstract: A composition comprises a compound of formula I wherein R1 is ethyl; R2 is OH; R3 is saccharide residue, where the residue is optionally substituted one or more times by a saccharide protective group, or a diamino acid residue, where the residue is optionally substituted one or more times by an amino acid protective group; R4 is methyl; R5 is methyl; Z is -(C=O)-C0-C4-alkyl or a covalent bond, and either a cholesterol absorption inhibitor such as ezetimibe, tiqueside or pamaqueside or carob pulp. The composition is useful for treating lipid metabolism disorders or metabolic syndrome, hyperlipideamia and arteriosclerotic manifestations.
Patent NZ-534927-A (NZ)
Title: Anticholinergic agents, method for producing the same and use thereof as medicaments
Inventor: GERMEYER SABINE
IPC: A61P11/06
Filed: 2003-01-21
Abstract: Anticholinergic agents of formula (1) are disclosed, in which X¯ and the groups A, B, R, R1, R2, R3, R3', R4, R4', Rx and Rx' are as defined in the specification. A method for producing said anticholinergic agents and to the use thereof as medicaments for the treatment of asthma, COPD, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal tract, spasms in the urinary tract and menstrual pain is also disclosed.
Patent NZ-537553-A (NZ)
Title: Saddle flashing formed by a single piece of durable plastic
Inventor: ALDRIDGE HAYDEN BRUCE
IPC: E04D13/14
Filed: 2005-01-10
Abstract: Disclosed is a weather proofing saddle flashing formed by a single piece of durable plastic and suitable for water-proofing timber members that penetrate a building envelope from outside to inside.
Patent NZ-538155-A (NZ)
Title: Taps and tap assemblies
Inventor: STONE DAVID GEORGE
IPC: E03C1/04
Filed: 2003-07-31
Abstract: A tap sub-assembly comprises a cover member (19) and a handle (18) rotatably attached thereto. The handle is adapted for connection with a tap operating spindle (17) extending outwardly from an architectural surface (13). The cover member is apertured for the passage therethrough of the spindle and is formed for attachment to the surface.
Patent NZ-538399-A (NZ)
Title: Fusion protein comprising an HPV E7 protein and a stress protein wherein the E7 protein is joined directly to the amino terminus of the stress protein
Inventor: MIZZEN LEE
IPC: A61K39/00
Filed: 1998-03-20
Abstract: A fusion protein comprising an HPV E7 protein or a functional portion and a stress protein wherein the E7 protein is joined directly to the amino terminus of the stress protein and is capable of inducing an immune response to the E& protein. Also disclosed is nucleic acid molecules and expression vectors encoding the fusion protein.
Patent NZ-541851-A (NZ)
Title: Textile reinforced wallboard
Inventor: MCLARTY GEORGE C
IPC: B32B29/02
Filed: 2005-08-17
Abstract: A reinforced wallboard comprising: a core material including chopped glass fibres; and at least one layer of a textile reinforcement embedded within the core.
Patent NZ-542665-A (NZ)
Title: Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
Inventor: THOMPSON JOHN E
IPC: C12Q1/68
Filed: 2004-03-05
Abstract: Provided is a use of an siRNA complementary to a polynucleotide encoding eIF-5A1 to manufacture a medicament to reduce levels of a cytokine in a cell comprising administering an siRNA capable of reducing expression of eIF-5A1, wherein the reducing of expression of eIF-5A1 reduces expression of said cytokine thereby reducing levels of the cytokine in the cell. Further provided are uses of similar siRNAs for reducing expression of p53, TNF-alpha, IL-1 or IL-6, or for increasing expression of Bcl-2. Also provided are similar method for treating specific diseases and cell types, including autoimmune diseases and epithelial cells.
Patent NZ-543946-A (NZ)
Title: HIV prodrugs cleavable by CD26
Inventor: DE KOCK HERMAN AUGUSTINUS
IPC: A61K47/48
Filed: 2004-05-10
Abstract: The disclosure relates to prodrugs of formula (I), wherein the variables shown in formula (I) are as described in the specification, of HIV inhibitory compounds whereby the HIV inhibitory compound is released or activated by proteolysis of a peptidic moiety. The disclosure also relates to methods of increasing oral uptake, modify serum protein binding, blood-brain barrier penetration or solubility and bioavailability of the HIV inhibitory compounds.
Patent NZ-546733-A (NZ)
Title: Glycopegylated factor IX
Inventor: BAYER ROBERT J
IPC: A61K/
Filed: 2004-12-03
Abstract: Disclosed are conjugates of a Factor IX peptide and poly(ethylene glycol) moieties. The conjugates are linked via an intact glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from glycosylated peptides by the action of a glycosyltransferase which ligates a modified sugar moiety onto a glycosyl residue on the peptide. Further provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
Patent NZ-552583-A (NZ)
Title: Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus
Inventor: MACDONALD ANGUS J
IPC: A61K39/12
Filed: 2005-06-15
Abstract: Disclosed is an immunogenic composition comprising: an antigenic moiety; and an adjuvant comprising an effective amount of Ov-ASP, or of at least one active subunit of Ov-ASP.
Patent NZ-552704-A (NZ)
Title: 3D thermal breast cancer detector
Inventor: ARNON BOAZ
IPC: G06V10/147
Filed: 2005-07-04
Abstract: A system for determining presence or absence of a thermally distinguishable object in a living body such as a tumour is disclosed. The system comprises a combined image generator configured for combining non-thermographic three-dimensional data of a three-dimensional tissue region in the living body with thermographic two-dimensional data of the tissue region so as to generate three-dimensional temperature data associated with the three-dimensional tissue region.
Patent NZ-552939-A (NZ)
Title: Food article packaging apparatus and method
Inventor: STACKLEY MARK ANTHONY
Filed: 2007-01-30
Abstract: Packaging apparatus and method are disclosed for inserting food articles into a bag of comparable size. The apparatus has a conveyor that orients the product along a longitudinal axis and delivers the food article to a tray disposed below the conveyor so the product drops from the conveyor and onto the tray. The tray and conveyor move at speeds selected so the product maintains its longitudinal orientation as it drops from the conveyor into the product tray. A bag scoop holds the bag mouth open while the tray carrying the product advances into the bag. A product stripper moves into a position behind the bagged product after passage of the tray so that when the tray returns to its start position, the stripper butts against the end of the product and holds the product while the tray slides out of the bag.
Patent NZ-554518-A (NZ)
Title: Cushioning device for a compression plate of an x-ray machine and method for using such eg in mammography
Inventor: HERMANN GEORGE D
IPC: A61B6/04
Filed: 2005-11-01
Abstract: A compression device includes a frame mountable to a mammography unit that includes a window disposed within an x-ray field of the mammography unit when the frame is mounted to the mammography unit, and a radiolucent compressible member connectable to the frame across the window for providing a compression surface within the x-ray field. For example, the compressible member may include a rigid backing member and a radiolucent pad, e.g., a gel pad, on the backing member. The backing member and frame may include tongue and groove or other connectors for connecting the compressible member to the frame. Optionally, one or more thin, radiolucent films may be removable from the compressible member, e.g., after obtaining x-rays from successive individual patients.
Patent NZ-561372-A (NZ)
Title: Method of simply analyzing drug
Inventor: WADA HIROO
IPC: G01N30/06
Filed: 2006-03-14
Abstract: Provided is a method for analyzing drugs accumulated in a solid biological sample which comprises the steps of introducing the solid biological sample into an injection needle, which has a closed apical end and an aperture in the lateral side near the apical end, inserting the needle into an injector of a chromatograph and injecting a carrier into the needle to conduct chromatography treatment.
Patent NZ-576976-A (NZ)
Title: Spinach line omb66-1101m
Inventor: BAERENDS BERNARDUS
IPC: A01H5/12
Filed: 2009-05-14
Abstract: Disclosed is a seed of spinach line OMB66-1101M a sample of seed of said line having been deposited under ATCC Accession Number PTA-9184. Further disclosed are tissue cultures of said spinach plant and methods of producing a seed of said spinach.
Patent NZ-577623-A (NZ)
Title: Tannate salt of rasagiline
Inventor: FRENKEL ANTON
IPC: A01N33/02
Filed: 2007-12-13
Abstract: Disclosed is the salt rasagiline tannate. Also disclosed is a process for making the salt.
Patent NZ-577956-A (NZ)
Title: Portable sign with arms movable by remote control from hidden within shroud to outside shroud
Inventor: PICARD ANDREW JOHN
IPC: E01F9/00
Filed: 2010-09-13
Abstract: The movable road sign 100 has an exterior shroud 101 supported on a movable chassis, and has one or more arms 102 movable by remote control from a location within the shroud 101 to deployed location outside the shroud 101 as shown.
Patent NZ-578877-A (NZ)
Title: Reduction of calcium in beverages using a powdered form of a pectin
Inventor: DUAN DAVID W
IPC: A23L29/231
Filed: 2008-01-25
Abstract: Disclosed is the use of a powdered form of a pectin or a salt thereof for reducing calcium in a beverage. Also disclosed are methods of reducing calcium in a beverage using a powdered form of a pectin and products produced by said method.
Patent NZ-582018-A (NZ)
Title: Multipotent/pluripotent cells and methods
Inventor: TAKAHASHI SHUNICHI
IPC: C12N5/07
Filed: 2008-06-13
Abstract: A human stem cell that is pluripotent, somatic, non-embryonic that has the property of long-term self-renewal. The human stem cell is generated by an in vitro method that comprises forcing the expression of an Oct3/4 polypeptide, a Sox2 polypeptide and a Klf4 polypeptide in a human somatic cell.
Patent NZ-584351-A (NZ)
Title: 2-S-benzyl substituted pyrimidines as CRTH2 antagonists
Inventor: TRAN MARIE CHANTAL S
IPC: A61P11/06
Filed: 2008-09-24
Abstract: 2-S-benzyl pyrimidine compounds of formula (I) are disclosed, wherein the variables are as defined in the specification. These compounds have CRTH2 (G-protein- coupled chemoattractant receptor, expressed on Th2 cells) antagonistic activity and are useful for the prophylaxis and treatment of diseases associated with CRTH2 activity, including the treatment of allergic diseases, eosinophil-related diseases and basophil-related diseases.
Patent NZ-584832-A (NZ)
Title: Acidic cleaning compositions
Inventor: VAN BUSKIRK GREGORY
IPC: C11D3/22
Filed: 2008-07-02
Abstract: Disclosed is an acidic hard surface cleaning composition comprising: a) 2 to 30 percent alkyl polyglucoside; b) 0.5 to 10 percent 2-hydroxycarboxylic acid; c) a fragrance containing 0.05 to 2.0 percent lemon oil or d-limonene; d) water; e) wherein the composition contains no additional surfactant, no additional organic f) builder, no organic solvent, and no additional disinfectant or sanitizer such as g) quaternary ammonium antimicrobial or biguanide; and h) wherein the pH is between 2 and 3.5.
Patent NZ-585959-A (NZ)
Title: Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same
Inventor: LIN SHIH-YAO
IPC: C07K16/28
Filed: 2008-12-18
Abstract: Disclosed is an antibody comprising a heavy chain and a light chain, wherein (a) the heavy chain comprises a heavy chain variable region comprising the three complementarity determining regions (CDRs) from the amino acid sequence of SEQ ID NO:1, and a heavy chain constant region comprising the amino acid sequence of SEQ ID NO:9, wherein the hinge region of the heavy chain constant region comprises at least one amino acid insertion, deletion or substitution; and (b) the light chain comprises a light chain variable region comprising the three complementarity determining regions from the amino acid sequence of SEQ ID NO:2, and a light chain constant region comprising the amino acid sequence of SEQ ID NO:10 and further comprising at least one amino acid insertion. Further disclosed is an antibody comprising a heavy chain and a light chain, wherein (a) the heavy chain comprises a heavy chain variable region comprising the three complementarity determining regions (CDRs) from the amino acid sequence of SEQ ID NO:1, and a heavy chain constant region comprising the amino acid sequence selected from SEQ ID NOS:11-30; and (b) the light chain comprises a light chain variable region comprising the three complementarity determining regions from the amino acid sequence of SEQ ID NO:2, and a light chain constant region comprising the amino acid sequence of SEQ ID NO:10 or a light chain constant region comprising the amino acid sequence of SEQ ID NO:10 and further comprising at least one amino acid insertion.